Loading…
Stryker acquired approximately 95.5% of the share capital of French spinal implant maker Vexim and plans a public buy-out offer and squeeze-out for the remaining shares at about $24.88 per share, expected in Q2 2018.
Stryker Corporation announced it has acquired control of VEXIM, a French medical device company listed on Euronext Growth in France.